Covaxin found to be well tolerated & safe in vaccine-naive & mRNA vaccinated in US study: Bharat Biotech partner Ocugen
Ocugen, Bharat Biotech’s US and Canada partner for Covid-19 vaccine Covaxin, on Monday said the Indian vaccine candidate was found to be well-tolerated in vaccine-naïve individuals and those previously vaccinated with mRNA vaccines in the United States.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
